SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cecilie Heramb, Per Olaf Ekstrøm, Kukatharmini Tharmaratnam, Eivind Hovig, Pål Møller, Lovise Mæhle, Ten modifiers of BRCA1 penetrance validated in a Norwegian series, Hereditary Cancer in Clinical Practice, 2015, 13, 1

    CrossRef

  2. 2
    Pål Møller, Kukatharmini Tharmaratnam, Anthony Howell, Paula Stavrinos, Sarah Sampson, Andrew Wallace, Anthony J. Maxwell, Anne Irene Hagen, D. Gareth Evans, Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography, Breast Cancer Research and Treatment, 2015, 152, 1, 87

    CrossRef

  3. 3
    CF Singer, D Muhr, C Rappaport, M-K Tea, D Gschwantler-Kaulich, A Fink-Retter, G Pfeiler, A Berger, P Sun, SA Narod, Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria, Clinical Genetics, 2014, 85, 1
  4. 4
    Pål Møller, Astrid Stormorken, Marit Muri Holmen, Anne Irene Hagen, Anita Vabø, Lovise Mæhle, The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation, Breast Cancer Research and Treatment, 2014, 144, 3, 607

    CrossRef

  5. 5
    Deborah Cragun, Tuya Pal, Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States, ISRN Oncology, 2013, 2013, 1

    CrossRef

  6. 6
    Pål Møller, Astrid Stormorken, Christoffer Jonsrud, Marit Muri Holmen, Anne Irene Hagen, Neal Clark, Anita Vabø, Ping Sun, Steven A. Narod, Lovise Mæhle, Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program, Breast Cancer Research and Treatment, 2013, 139, 1, 155

    CrossRef